-
1
المصدر: Value in Health. 24:839-845
مصطلحات موضوعية: Technology Assessment, Biomedical, Time Factors, Cost effectiveness, Cost-Benefit Analysis, Recombinant Fusion Proteins, media_common.quotation_subject, Spinal Muscular Atrophies of Childhood, Antibodies, Monoclonal, Humanized, Hemophilia A, Immunotherapy, Adoptive, Drug Costs, 03 medical and health sciences, 0302 clinical medicine, Drug Therapy, Cost Savings, Antibodies, Bispecific, Health care, Economics, Humans, 030212 general & internal medicine, health care economics and organizations, media_common, Biological Products, Actuarial science, business.industry, Lymphoma, Non-Hodgkin, 030503 health policy & services, Health Policy, Remission Induction, Public Health, Environmental and Occupational Health, Health technology, Genetic Therapy, Health Care Costs, Cost-effectiveness analysis, Economic surplus, Payment, Models, Economic, Treatment Outcome, Systematic review, Economic model, Quality-Adjusted Life Years, 0305 other medical science, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f8b83286ab6ace110399ee1487f5e4eTest
https://doi.org/10.1016/j.jval.2021.02.008Test -
2
المصدر: Value Health
مصطلحات موضوعية: Male, Filgrastim, media_common.quotation_subject, Drug Costs, Article, Insurance Claim Review, 03 medical and health sciences, 0302 clinical medicine, Cost Savings, Humans, Medicine, In patient, Longitudinal Studies, 030212 general & internal medicine, Medical prescription, Biosimilar Pharmaceuticals, health care economics and organizations, media_common, Insurance, Health, business.industry, 030503 health policy & services, Health Policy, Public Health, Environmental and Occupational Health, Interrupted time series, Interrupted Time Series Analysis, Biosimilar, Middle Aged, Payment, United States, Confidence interval, Cost sharing, Female, Health Expenditures, 0305 other medical science, business, Demography, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb853d7da7bce2a553f5e03652ee5914Test
https://doi.org/10.1016/j.jval.2020.06.014Test -
3
المؤلفون: B. C. Trindade, Sandra Avila, Rebeca Gouget Sérgio Miranda, Silvio Gioppato, Andrei C. Sposito, Wilson Nadruz, Luiz Sergio F. Carvalho, Marta Duran Fernandez, Jose C. Quinaglia e Silva, José Roberto Matos Souza
المصدر: Value in Health. 23:1570-1579
مصطلحات موضوعية: Male, Percentile, Acute coronary syndrome, medicine.medical_treatment, Population, Machine learning, computer.software_genre, Logistic regression, Machine Learning, Cost Savings, Risk Factors, medicine, Humans, Acute Coronary Syndrome, education, Socioeconomic status, Dialysis, Aged, education.field_of_study, business.industry, Health Policy, Public Health, Environmental and Occupational Health, Area under the curve, Health Care Costs, medicine.disease, Treatment Outcome, Female, Artificial intelligence, Morbidity, business, computer, Mace
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::258033fe4392898c663b287ceda00442Test
https://doi.org/10.1016/j.jval.2020.08.2091Test -
4
المصدر: Value in Health. 22:S18-S23
مصطلحات موضوعية: Cost–benefit analysis, Cost effectiveness, Computer science, Cost-Benefit Analysis, Health Policy, Treatment outcome, Public Health, Environmental and Occupational Health, MEDLINE, Health Care Costs, Decision Support Techniques, Cost savings, Quality-adjusted life year, Value-Based Purchasing, Models, Economic, Outcome and Process Assessment, Health Care, Treatment Outcome, Cost Savings, Humans, Value assessment, Operations management, Quality-Adjusted Life Years, Value-Based Health Insurance
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cf16b2d81856154468a4e7ba29e7a60Test
https://doi.org/10.1016/j.jval.2019.04.1914Test -
5
المؤلفون: Patrick P. Gleason, Richard J. Willke, Richard H. Chapman, Joshua J Seidman, Lowell E. Schnipper
المصدر: Value in Health. 22:S7-S11
مصطلحات موضوعية: Actuarial science, Cost–benefit analysis, Cost-Benefit Analysis, Health Policy, Treatment outcome, Public Health, Environmental and Occupational Health, MEDLINE, Health Care Costs, Cost savings, Value-Based Purchasing, Outcome and Process Assessment, Health Care, Treatment Outcome, Cost Savings, Value (economics), Economics, Humans, Value-Based Health Insurance, Current (fluid)
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc4f74193a36036659a1df04849ab49bTest
https://doi.org/10.1016/j.jval.2019.04.1916Test -
6
المؤلفون: John Cairns, Michael Ankcorn, Frank Sandmann, Richard S. Tedder
المصدر: Value in Health. 23:309-318
مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, Time Factors, Cost effectiveness, Cost-Benefit Analysis, medicine.disease_cause, Polymerase Chain Reaction, Risk Assessment, State Medicine, 03 medical and health sciences, 0302 clinical medicine, Hepatitis E virus, Cost Savings, Predictive Value of Tests, Risk Factors, Prevalence, medicine, Humans, Mass Screening, Serologic Tests, 030212 general & internal medicine, health care economics and organizations, Cost–benefit analysis, business.industry, 030503 health policy & services, Health Policy, Public Health, Environmental and Occupational Health, Health Care Costs, Organ Transplantation, Cost-effectiveness analysis, Clinical Enzyme Tests, Markov Chains, United Kingdom, Annual Screening, Hepatitis E, Models, Economic, Treatment Outcome, Economic evaluation, Quality-Adjusted Life Years, 0305 other medical science, business, Solid organ transplantation, Hepatitis E virus infection
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::832a4e7f7275199d4126d34896acdddcTest
https://doi.org/10.1016/j.jval.2019.09.2751Test -
7
المؤلفون: David Tordrup, Andrew Ball, Karin Stenberg, Jeremy A. Lauer, Mehlika Toy, Nick Scott, David W. Hutton, Yvan Hutin, Jagpreet Chhatwal
المصدر: Value in Health
مصطلحات موضوعية: Cost effectiveness, Hepatitis C virus, Cost-Benefit Analysis, Psychological intervention, viral hepatitis, medicine.disease_cause, Antiviral Agents, Gross domestic product, 03 medical and health sciences, 0302 clinical medicine, elimination, Cost Savings, Environmental health, medicine, Per capita, Humans, 030212 general & internal medicine, Disease Eradication, cost-effectiveness, Developing Countries, health care economics and organizations, Hepatitis B virus, Hepatitis, DALY, business.industry, 030503 health policy & services, Health Policy, Public Health, Environmental and Occupational Health, medicine.disease, Hepatitis B, Hepatitis C, Income, Quality-Adjusted Life Years, 0305 other medical science, business, Viral hepatitis, Economic Evaluation
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48cb80d839d325612153b463ff970ca2Test
http://europepmc.org/articles/PMC7806510Test -
8
المؤلفون: Mark McClellan, Federico Augustovski
المصدر: Value in Health. 22:S4-S6
مصطلحات موضوعية: Actuarial science, Cost–benefit analysis, Policy making, Cost-Benefit Analysis, Health Policy, Treatment outcome, Public Health, Environmental and Occupational Health, MEDLINE, Health Care Costs, Cost savings, Value-Based Purchasing, Outcome and Process Assessment, Health Care, Treatment Outcome, Cost Savings, Value-based pricing, Humans, Value-Based Health Insurance, Business, Current (fluid), Policy Making
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59e735797b940d5714bdeb9d155dece9Test
https://doi.org/10.1016/j.jval.2019.04.1918Test -
9
المؤلفون: Joseph T. Kannarkat, Natasha Parekh, Chester B. Good
المصدر: Value in Health. 23:154-156
مصطلحات موضوعية: Drug Industry, Cost-Benefit Analysis, Contracts, Drug Costs, Health Services Accessibility, Cost Savings, Health care, Humans, Value-Based Health Insurance, Policy Making, health care economics and organizations, Reimbursement, Health Care Rationing, Actuarial science, business.industry, Health Policy, Tying, Drug cost, Public Health, Environmental and Occupational Health, Value-Based Purchasing, Incentive, Insurance, Health, Reimbursement, Value (economics), Health Expenditures, Drug pricing, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::535c4979de6ddeb28397f8a66aac8893Test
https://doi.org/10.1016/j.jval.2019.10.009Test -
10
المؤلفون: Edith A. Perez, Hans-Peter Goertz, Joseph B. Babigumira, Louis P. Garrison, Solomon J. Lubinga, C. Tournier
المصدر: Value in Health. 22:408-415
مصطلحات موضوعية: Oncology, Time Factors, Receptor, ErbB-2, Cost-Benefit Analysis, medicine.medical_treatment, Antineoplastic Agents, Immunological, 0302 clinical medicine, Trastuzumab, Antineoplastic Combined Chemotherapy Protocols, 030212 general & internal medicine, Neoplasm Metastasis, health care economics and organizations, Randomized Controlled Trials as Topic, Aged, 80 and over, education.field_of_study, 030503 health policy & services, Health Policy, Cost-effectiveness analysis, Middle Aged, Markov Chains, Models, Economic, Treatment Outcome, Chemotherapy, Adjuvant, Disease Progression, Female, Quality-Adjusted Life Years, Pertuzumab, 0305 other medical science, Adjuvant, medicine.drug, medicine.medical_specialty, Population, Breast Neoplasms, Antibodies, Monoclonal, Humanized, Disease-Free Survival, Drug Costs, 03 medical and health sciences, Breast cancer, Cost Savings, Internal medicine, medicine, Humans, education, Aged, Chemotherapy, business.industry, Public Health, Environmental and Occupational Health, medicine.disease, Economic evaluation, Quality of Life, Neoplasm Recurrence, Local, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfbba2988fa86af230f4ddd4fc5b41f9Test
https://doi.org/10.1016/j.jval.2018.11.014Test